About 50% of patients have headache after a hemorrhagic stroke, and more than a third report severe pain — yet headache care ...

Ivarmacitinib, a highly selective Janus kinase 1 inhibitor, tops placebo in managing signs and symptoms of active ankylosing ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...